Total Payments
$9,075
2024 Payments
$1,660
Companies
22
Transactions
377
Medicare Patients
1,224
Medicare Billing
$234,125
Payment Breakdown by Category
Food & Beverage$9,028 (99.5%)
Education$46.91 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,028 | 376 | 99.5% |
| Education | $46.91 | 1 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,371 | 112 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $1,132 | 45 | $0 (2024) |
| ITI, Inc. | $836.19 | 38 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $632.17 | 36 | $0 (2024) |
| Bausch Health US, LLC | $593.19 | 19 | $0 (2023) |
| Neurocrine Biosciences, Inc. | $490.98 | 14 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $458.17 | 17 | $0 (2024) |
| Axsome Therapeutics, Inc. | $446.59 | 9 | $0 (2024) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $278.67 | 15 | $0 (2024) |
| Corium, LLC | $259.14 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,660 | 70 | Janssen Pharmaceuticals, Inc ($361.12) |
| 2023 | $3,227 | 117 | ABBVIE INC. ($862.55) |
| 2022 | $2,338 | 97 | ABBVIE INC. ($590.01) |
| 2021 | $1,850 | 93 | AbbVie Inc. ($918.86) |
All Payment Transactions
377 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $10.58 | General |
| Category: PSYCHIATRY | ||||||
| 12/17/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $7.10 | General |
| Category: PSYCHIATRY | ||||||
| 12/16/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $13.62 | General |
| Category: Central Nervous System | ||||||
| 12/13/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $7.08 | General |
| Category: PSYCHIATRY | ||||||
| 12/12/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $23.12 | General |
| Category: Neuropsychiatry | ||||||
| 12/09/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $22.46 | General |
| Category: PSYCHIATRY | ||||||
| 12/06/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $32.19 | General |
| Category: Neuroscience | ||||||
| 12/04/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $124.99 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/04/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $21.73 | General |
| Category: PSYCHIATRY | ||||||
| 12/02/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/01/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $26.47 | General |
| Category: PSYCHIATRY | ||||||
| 11/20/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $17.03 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/18/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug) | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: PSYCHIATRY | ||||||
| 11/16/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $22.12 | General |
| Category: PSYCHIATRY | ||||||
| 11/07/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $104.95 | General |
| Category: Psychology/Psychiatric | ||||||
| 11/05/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $8.84 | General |
| Category: Central Nervous System | ||||||
| 11/04/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $33.94 | General |
| Category: Neuroscience | ||||||
| 10/22/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug) | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: PSYCHIATRY | ||||||
| 10/15/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $28.81 | General |
| Category: Neuroscience | ||||||
| 10/11/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $23.57 | General |
| Category: Neurology | ||||||
| 10/09/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $37.18 | General |
| Category: Psychiatry/Psychology | ||||||
| 10/09/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $28.61 | General |
| Category: PSYCHIATRY | ||||||
| 09/28/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $10.83 | General |
| Category: PSYCHIATRY | ||||||
| 09/27/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $27.01 | General |
| Category: Neurology | ||||||
| 09/19/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 264 | 656 | $169,942 | $43,700 |
| 2022 | 6 | 304 | 955 | $200,330 | $68,839 |
| 2021 | 6 | 343 | 932 | $191,250 | $66,662 |
| 2020 | 4 | 313 | 818 | $168,560 | $54,924 |
Total Patients
1,224
Total Services
3,361
Medicare Billing
$234,125
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 101 | 291 | $82,559 | $20,124 | 24.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 21 | 86 | $33,773 | $8,944 | 26.5% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 74 | 172 | $25,660 | $7,219 | 28.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 42 | 80 | $16,457 | $3,856 | 23.4% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 26 | 27 | $11,493 | $3,557 | 31.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 111 | 422 | $105,420 | $31,308 | 29.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 22 | 137 | $45,210 | $15,727 | 34.8% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 90 | 253 | $17,710 | $11,230 | 63.4% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 44 | 44 | $17,160 | $5,581 | 32.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 26 | 59 | $10,030 | $2,756 | 27.5% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2022 | 11 | 40 | $4,800 | $2,238 | 46.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 108 | 424 | $106,000 | $34,212 | 32.3% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 83 | 226 | $15,820 | $9,908 | 62.6% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 74 | 74 | $28,860 | $8,901 | 30.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 14 | 49 | $16,090 | $5,525 | 34.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 53 | 108 | $18,360 | $5,209 | 28.4% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2021 | 11 | 51 | $6,120 | $2,908 | 47.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 83 | 361 | $90,250 | $26,647 | 29.5% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 79 | 271 | $18,970 | $13,213 | 69.7% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2020 | 125 | 126 | $49,140 | $11,841 | 24.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 26 | 60 | $10,200 | $3,224 | 31.6% |
About Jonathan Edens, PA
Jonathan Edens, PA is a Physician Assistant healthcare provider based in Sacramento, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/03/2019. The National Provider Identifier (NPI) number assigned to this provider is 1184265845.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jonathan Edens, PA has received a total of $9,075 in payments from pharmaceutical and medical device companies, with $1,660 received in 2024. These payments were reported across 377 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($9,028).
As a Medicare-enrolled provider, Edens has provided services to 1,224 Medicare beneficiaries, totaling 3,361 services with total Medicare billing of $234,125. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Physician Assistant
- Location Sacramento, CA
- Active Since 10/03/2019
- Last Updated 12/13/2023
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1184265845
Products in Payments
- VRAYLAR (Drug) $2,333
- CAPLYTA (Drug) $1,115
- REXULTI (Drug) $960.05
- APLENZIN (Drug) $593.19
- INGREZZA (Drug) $490.98
- Auvelity (Drug) $446.59
- INVEGA SUSTENNA (Drug) $396.16
- Azstarys (Drug) $259.14
- TRINTELLIX (Drug) $255.08
- AUSTEDO (Drug) $249.93
- ABILIFY ASIMTUFII (Drug) $240.09
- Austedo XR (Drug) $219.36
- ARISTADA (Drug) $201.62
- NEUROSTAR TMS THERAPY SYSTEM (Device) $188.36
- COBENFY (Drug) $179.20
- UZEDY (Drug) $162.88
- HETLIOZ (Drug) $151.33
- BELSOMRA (Drug) $102.51
- ABILIFY MAINTENA (Drug) $87.65
- LATUDA (Drug) $76.51
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Sacramento
Mr. Franklin Cline, Pa-C, PA-C
Physician Assistant — Payments: $346,059
Physician Assistant $346,059
Mr. Antonio Luza, Pa-C, PA-C
Physician Assistant — Payments: $19,162
Physician Assistant $19,162
Mr. Joseph Karpel, Pa-C, Mph, PA-C, MPH
Physician Assistant — Payments: $12,480
Physician Assistant $12,480
Alexa Herzig
Physician Assistant — Payments: $10,684
Physician Assistant $10,684
Ms. Sandra Kemptner, Pa-C, PA-C
Physician Assistant — Payments: $10,567
Physician Assistant $10,567
Glenn Quijano, Pa-C, PA-C
Physician Assistant — Payments: $9,852
Physician Assistant $9,852